Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL1973104 | 0.96 | TSHR (0.38) | TSHRTDP1ALDH1A1 | |
| SCHEMBL14350954 | 0.83 | TSHR (0.33) | TSHRTDP1ALDH1A1 | |
| SCHEMBL20347936 | 0.81 | TSHR (0.39) | TSHRTDP1 | |
| SCHEMBL2978418 | 0.81 | TSHR (0.32) | TSHRTDP1 | |
| SCHEMBL25756291 | 0.81 | TSHR (0.32) | TSHRTDP1 | |
| SCHEMBL13366742 | 0.81 | ALDH1A1 (0.35) | TSHRTDP1ALDH1A1 | |
| SCHEMBL20347937 | 0.81 | TSHR (0.39) | TSHRTDP1 | |
| SCHEMBL28709716 | 0.81 | CYP2D6 (0.35) | TSHRTDP1 | |
| SCHEMBL1033095 | 0.79 | TSHR (0.39) | TSHRTDP1ALDH1A1 | |
| SCHEMBL23880598 | 0.78 | ALDH1A1 (0.56) | TSHRTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006060225-A2 | PROCESS FOR ASYMMETRIC SYNTHESIS OF HEXAHYDROPYRIMIDO[1,2-A] AZEPINE-2-CARBOXAMIDES AND RELATED COMPOUNDS | MERCK & CO., INC. (US) | 2006-06-08 | — | — | WO | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| CN-1714070-A | Vitamin d receptor modulators | LILLY CO ELI (US) | 2005-12-28 | — | — | CN | claimed |
| US-5739250-A | ONE STEP COPOLYMERIZATION WITHOUT ISOLATING THE INTERMEDIATE PREPOLYMER, CHAIN EXTENSION TO ELIMINATE VOLATILE MATERIAL | BAYER AKTIENGESELLSCHAFT (DE) | 1998-04-14 | — | — | US | claimed |
| US-5663265-A | FREE RADICAL COPOLYMERIZATION FOR COATINGS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-09-02 | — | — | US | claimed |
| US-5596057-A | INTERPOLYMER FROM STERICALLY HINDERED UNSATURATED ESTERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-01-21 | — | — | US | claimed |
| US-20250215318-A1 | ETCHING COMPOSITION, ETCHING METHOD USING SAME, AND METHOD FOR MANUFACTURING ELECTRONIC COMPONENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2025-07-03 | — | — | US | disclosed |
| CN-119176891-A | Ziegler-Natta catalyst for olefin polymerization and preparation method thereof | 中国科学院大连化学物理研究所 | 2024-12-24 | — | — | CN | disclosed |
| CN-112859516-B | Material for forming organic film, pattern forming method, and polymer | 信越化学工业株式会社 | 2024-09-24 | — | — | CN | disclosed |
| EP-3828630-B1 | MATERIAL FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND POLYMER | SHINETSU CHEMICAL CO (JP) | 2024-06-19 | — | — | EP | disclosed |
| CN-117683220-A | Preparation method of hydrophilic plasticized polyvinyl chloride plastic | 北京化工大学 | 2024-03-12 | — | — | CN | disclosed |
| US-20230365525-A1 | ANTIVIRAL COMPOUNDS | ENANTA PHARMACEUTICALS, INC. | 2023-11-16 | — | — | US | disclosed |
| US-20230365525-A1 | ANTIVIRAL COMPOUNDS | ENANTA PHARMACEUTICALS, INC. | 2023-11-16 | — | — | US | disclosed |
| CN-1112569-A | Copolymers containing hydroxyl and carboxyl groups, their preparation, and their use in high-solids coating compositions | HOECHST AG (DE) | 1995-11-29 | — | — | CN | disclosed |
| EP-0680977-A1 | Copolymers containing hydroxyl and carboxyl groups, their preparation and their use in high solid coatings | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-11-08 | — | — | EP | disclosed |
| CN-1106417-A | Copolymers containing hydroxl groups, their preparation, and their use in high-solids coating compositions | HOECHST AG (DE) | 1995-08-09 | — | — | CN | disclosed |
| EP-0646047-A4 | ETCH-RESISTANT COATING. | BASF CORP (US) | 1995-05-17 | — | — | EP | disclosed |
| EP-0646047-A1 | ETCH-RESISTANT COATING | BASF CORPORATION (US) | 1995-04-05 | — | — | EP | disclosed |
| EP-0638591-A2 | Copolymers containing hydroxyl groups, their preparation and their use in high solids coatings | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-02-15 | — | — | EP | disclosed |
| WO-1992018255-A1 | ETCH-RESISTANT COATING | BASF CORPORATION (US) | 1992-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365525-A1 | ANTIVIRAL COMPOUNDS | ACE, ZC3HAV1, SARS1 | TSHR 3807/4885TDP1 2091/4885ALDH1A1 2152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.